add_icon

Morepen Laboratories

128.33
+6.11
(5.00%)
Market Cap
7,031.89 Cr
PE Ratio
47.39
Volume
58,68,833.00
Day High - Low
128.33 - 117.50
52W High-Low
150.70 - 33.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
7,031.89 Cr
EPS
1.73
PE Ratio
47.39
PB Ratio
5.35
Book Value
22.75
EBITDA
146.90
Dividend Yield
0.16 %
Industry
Healthcare
Return on Equity
7.67
Debt to Equity
0.13
Forecast For
Actual

Company News

View All News
Caret
positive
Morepen Laboratories submitted its first US ANDA for Sitagliptin Tablets, marking a strategic shift from API manufacturing to integrated CDMO services and finished dosage development.
neutral
Morepen Laboratories approved Sanjay Suri's elevation to Managing Director and extended the timeline for hiving off its Medical Devices business into a subsidiary.
positive
Morepen Laboratories has finished the first phase of its manufacturing expansion ahead of schedule. Reactor capacity for API and CDMO rose from 535 KL to 614 KL, supporting commercial scale-up.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,734.60
#1 4,16,188.64
35.03
#1 61,673.90
12.69
#1 11,565
26.53
36.68
9,071.00
2,40,806.55
84.18
11,067.00
13.95
2,568
65.50
50.22
4,584.00
1,74,360.63
81.77
13,886.20
20.34
2,138
3.28
36.89
1,130.20
1,12,737.88
24.57
27,657.90
17.64
5,026
-34.90
46.34
2,029.20
1,09,640.16
101.64
6,867.80
22.01
890
#1 123.93
62.41
1,309.60
1,05,797.14
32.02
29,044.60
2.24
3,870
-39.18
39.51
1,214.40
1,01,363.57
32.50
35,058.60
3.90
4,158
-69.10
60.90
1,670.00
96,088.11
26.10
34,145.20
5.56
3,503
25.21
51.16
2,325.00
96,032.98
47.32
14,636.40
14.85
1,938
29.13
45.25
1,946.10
88,993.20
#1 16.15
29,038.90
#1 26.75
5,356
16.00
31.41
Growth Rate
Revenue Growth
-0.16 %
Net Income Growth
-18.98 %
Cash Flow Change
1.81 %
ROE
-22.84 %
ROCE
-26.33 %
EBITDA Margin (Avg.)
-23.57 %

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Feb 2023 CHANGE OF NAME Change Of Name
NA
02 Feb 2023 28.05 28.05
18 Mar 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
18 Mar 2024 53.30 41.96
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 96.19 86.63
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 82.35 83.34
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 64.67 66.62
10 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
10 Feb 2025 68.14 61.26
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 59.26 56.23
06 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2025 58.45 56.56
30 Aug 2025 DIVIDEND Dividend
₹ 0.20 /share
29 Aug 2025 56.23 46.67
06 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Sept 2025 56.56 49.31
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 47.44 46.59
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 35.91 39.51
26 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2026 43.01 43.74
04 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Aug 2026 56.66 57.68
19 Sept 2026 DIVIDEND Dividend
₹ 0.20 /share
18 Sept 2026 43.74 120.90
26 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2026 57.68 120.45

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
-7
0.00%
0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.27%
0
0.00%
0.04%

Technical Indicators

RSI(14)
Neutral
50.83
ATR(14)
Less Volatile
8.37
STOCH(9,6)
Neutral
54.07
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-1.52
ADX(14)
Strong Trend
32.83
UO
Bearish
42.96
ROC
Uptrend And Accelerating
4.82
WillR
Oversold
-81.05